Clinical Trial Update: Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC

View source ↗

Summary

This clinical trial update describes a real-world observational study of targeted therapies in patients with advanced ROS1-positive non-small cell lung cancer, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Targeted therapy for ROS1-positive NSCLC

Snippet

Sponsor: National Cancer Center, China | Conditions: Non-Small Cell Lung Cancer, ROS1 Gene Rearrangement | Status: NOT_YET_RECRUITING